effects of glp-1 receptor agonists on neurological complications of diabetes An analysis the role glucagon-like peptide-1 in cognitive and mental health disorders Role of glucagon-like peptide-1 receptor
Description
From cravings to avoidance, here's what thousands of GLP-1 users are saying about how their relationship with food has changed.
The product is formulated to support healthy weight management
Compared with SGLT-2 inhibitor use, GLP-1 receptor agonist use was not associated with an increased risk of pulmonary aspiration (pooled risk ratio 0.98, 95% CI 0.73 to 1.31), although it was associated with a higher risk for discontinuation of endoscopy (1.99, 1.56 to 2.53)
GLP-1 receptor agonists trace their roots back to exendin-4, a peptide isolated from Gila monster venom in the early 1990san insight that eventually led to exenatide and reshaped the treatment of diabetes and metabolic disease
Type 2 diabetes represents a growing challenge for global public health
Novo Nordisk is putting down up to US$362m to tap into Ascendis TransCon technology for treatments in metabolic and cardiovascular diseases
